Volume: 8

1. Surgical Option for Sufficient Safety Margine in Locally Advanced Type II Cardia Cancer-Left Colon Interposition. Page:97—103
2. Clinical Features of Patients with Stage IV Gastric Cancer. Page:91—96
3. Evaluation of the Safety and Feasibility of D2 Lymphadenectomy in Elderly Patients with Gastric Cancer. Page:85—90
4. Short-term Surgical Outcomes after Laparoscopic D2 Lymphadenectomy in Patients with Distal Gastric Cancer. Page:79—84
5. The Correlation between the Expression of E-cadherin, VEGF-C, VEGF-D and the Real Extent of Lymph Node Metastases using Cytokeratin 18 in Early Gastric Cancer. Page:70—78
6. Preoperative Chemotherapy in Advanced Stomach Cancer (Cons). Page:65—69
7. Preoperative Chemotherapy in Advanced Stomach Cancer (Pros). Page:57—64
8. Primary Gastric Choriocarcinoma. Page:47—52
9. Modified FOLFOX-6 Chemotherapy for Recurrent or Inoperable Gastric Cancer Patients. Page:40—46
10. Efficacy and Safety of Intraveous Iron Sucrose in the Perioperatively Anemic Patients of Gastrectomy. Page:35—39
11. Laparoscopic Assisted Total Gastrectomy (LATG) with Extracorporeal Anastomosis and using Circular Stapler for Middle or Upper Early Gastric Carcinoma: Reviews of Single Surgeon's Experience of 48 Consecutive Patients. Page:27—34
12. The Early Experience with a Laparoscopy-assisted Pylorus-preserving Gastrectomy: A Comparison with a Laparoscopy-assisted Distal Gastrectomy with Billroth-I Reconstruction. Page:20—26
13. Survival Rates after Operation for Gastric Cancer: Fifteen-year Experience at a Korea Cancer Center Hospital. Page:9—19
14. Extended Approach of EMR/ESD in Stomach Cancer: CON. Page:5—8
15. Extended Approach of EMR (ESD) in Stomach Cancer: Pro. Page:1—4
16. Efficacy of Intravenous Iron Sucrose for Treating Anemia after Gastrectomy. Page:262—266
17. Management of an Intra-abdominal Fluid Collection after Gastric Cancer Surgery. Page:256—261
18. The Diagnostic Utility of PET-CT for the Preoperative Evaluation of Lymph Node Metastasis in Gastric Cancer Patients. Page:250—255
19. The Results of Gastric Cancer Surgery during the Early Stage of a Training Hospital. Page:244—249
20. The Risk Factors for Infectious Complications after Elective Gastrectomy for Gastric Cancer. Page:237—243
21. The Learning Curve of Laparoscopy-assisted Distal Gastrectomy (LADG) for Cancer. Page:232—236
22. The Surgical Outcome for Gastric Submucosal Tumors: Laparoscopy vs. Open Surgery. Page:225—231
23. Colon Interposition as a Gastric Substitute after Performing Gastrectomy in Patients with Gastric Cancer. Page:217—224
24. The Clinicopathological Characteristics of Adenocarcinoma of the Gastro-esophageal Junction. Page:210—216
25. The Clinicopathologic Characteristics of Neuroendocrine Tumor of the Stomach. Page:204—209
26. The Clinicopathologic Features and Prognosis of Multiple Early Gastric Cancer. Page:198—203
27. The Clinical Significance and Detection of Intraperitoneal Micrometastases by ThinPrep(R) Cytology with Peritoneal Lavage Fluid in Patients with Advanced Gastric Cancer. Page:189—197
28. The Immunohistochemical Expression of Nuclear Retinoid Receptor and CREB in Gastric Adenocarcinoma. Page:182—188
29. Correlation between the Serum Leptin Level and the Expression of Leptin in Stomach Cancer Patients. Page:176—181
30. The Relation between Microsatellite Instability and the Thymidylate Synthase Expression in Gastric Cancer. Page:169—175
31. Surgical Treatment for Chronic Peptic Ulcer with Gastric Outlet Obstruction. Page:160—165
32. The Use of Short-term Antimicrobial Prophylaxis in Elective Surgery for Gastric Cancer. Page:154—159
33. The Surgical Treatment of Malignant Bowel Obstruction Caused by Recurrent Gastric Cancer. Page:148—153
34. Laparoscopy-assisted Total Gastrectomy for Advanced Upper Gastric Cancer: Comparison with Open Total Gastrectomy. Page:141—147
35. Clinicopathologic Characteristics of Stage IV Early Gastric Cancer. Page:136—140
36. The Usefulness of Serum Tumor Markers as a Predictor of Peritoneal Metastasis in Patients with Gastric Carcinoma: CA 19-9 and CEA. Page:129—135
37. The Effects of Mistletoe Extract and Anti-cancer Drugs on the Apoptosis of Gastric Cancer Cells. Page:120—128
38. An Association of C/T Polymorphism in the TFF1 Gene and the Susceptibility to Gastric Cancer. Page:113—119